Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Physical exercise can enhance development of new brain cells

Physical exercise can enhance development of new brain cells

Older adults who take more steps per day perform better on memory tasks

Older adults who take more steps per day perform better on memory tasks

Brain ageing acceleration ‘nearly inevitable’ with age

Brain ageing acceleration ‘nearly inevitable’ with age

Olfactory testing uses extended to Alzheimer’s disease

Olfactory testing uses extended to Alzheimer’s disease

Exercise can impact cortical thickness in older adults with mild cognitive impairment

Exercise can impact cortical thickness in older adults with mild cognitive impairment

UF Health investigators make new discovery about Huntington's disease

UF Health investigators make new discovery about Huntington's disease

Researchers develop simple visual test to identify individuals' level of executive cognitive abilities

Researchers develop simple visual test to identify individuals' level of executive cognitive abilities

College courses may increase cognitive capacity, reduce debilitating effects of dementia for older adults

College courses may increase cognitive capacity, reduce debilitating effects of dementia for older adults

Drug prevents onset of cognitive and cellular effects in mouse model of Alzheimer’s disease

Drug prevents onset of cognitive and cellular effects in mouse model of Alzheimer’s disease

Health care costs for Alzheimer's disease patients increase a year before diagnosis

Health care costs for Alzheimer's disease patients increase a year before diagnosis

Researchers find molecular mechanism that may be responsible for development of amyloidoses

Researchers find molecular mechanism that may be responsible for development of amyloidoses

Experimental drug candidate aimed at combating Alzheimer's disease has anti-aging effects

Experimental drug candidate aimed at combating Alzheimer's disease has anti-aging effects

TGen: PPF drug could help treat patients with deadly brain cancer

TGen: PPF drug could help treat patients with deadly brain cancer

Reproductive history associated with cognitive impairment risk in postmenopausal women

Reproductive history associated with cognitive impairment risk in postmenopausal women

Older populations in rural areas face special health care challenges

Older populations in rural areas face special health care challenges

Mayo Clinic's Florida campus awarded NIH grant to identify vascular risk factors in aging and dementia

Mayo Clinic's Florida campus awarded NIH grant to identify vascular risk factors in aging and dementia

Berkeley Lab scientists identify genetic factors that influence neurological disorders and body weight

Berkeley Lab scientists identify genetic factors that influence neurological disorders and body weight

Brain scans may predict possibility of recovering from coma

Brain scans may predict possibility of recovering from coma

ApoE4-carrying men with Alzheimer's disease at risk of brain bleeds

ApoE4-carrying men with Alzheimer's disease at risk of brain bleeds

New progenitor cells differentiate into mature cell types, prevent risk of unwanted tumors

New progenitor cells differentiate into mature cell types, prevent risk of unwanted tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.